Oncocyte names Gisela Paulsen COO effective Oct 4, 2021; salary $390k, options

Insight Molecular Diagnostics Inc.

Gisela Paulsen appointed Chief Operating Officer, effective October 4, 2021.
Annual salary of $390,000 with target bonus of 50% of base salary.
One-time sign-on award of 375,000 stock options vesting over four years.
Previously General Manager of Exact Sciences' Precision Oncology and senior roles at Roche/Genentech.
Severance agreement provides 12 months base salary and accelerated vesting upon certain terminations.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Gisela Paulsen

Chief Operating Officer

IMDX · Insight Molecular Diagnostics Inc.

Effective: 2021-10-04
Filed: October 7, 2021, 7:59 PM ET

We have appointed Gisela Paulsen as Chief Operating Officer effective October 4, 2021.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Gisela Paulsen was appointed as Chief Operating Officer at Insight Molecular Diagnostics Inc..

Action: appointed
Role: Chief Operating Officer

Exact text from the filing

We have appointed Gisela Paulsen as Chief Operating Officer effective October 4, 2021.

View on SEC.gov

Insight Molecular Diagnostics Inc. filing history →

Source: SEC EDGAR

accession 0001493152-21-024884

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.